- Home
- ZGN vs AZTA Comparison
ZGN vs AZTA Comparison
Compare ZGN & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- AZTA
- Stock Information
- Founded
- ZGN 1910
- AZTA 1978
- Country
- ZGN Italy
- AZTA United States
- Employees
- ZGN N/A
- AZTA N/A
- Industry
- ZGN Apparel
- AZTA Industrial Machinery/Components
- Sector
- ZGN Consumer Discretionary
- AZTA Technology
- Exchange
- ZGN Nasdaq
- AZTA Nasdaq
- Market Cap
- ZGN 1.9B
- AZTA 1.8B
- IPO Year
- ZGN N/A
- AZTA 1995
- Fundamental
- Price
- ZGN $6.68
- AZTA $29.25
- Analyst Decision
- ZGN Buy
- AZTA Buy
- Analyst Count
- ZGN 2
- AZTA 4
- Target Price
- ZGN $8.05
- AZTA $58.75
- AVG Volume (30 Days)
- ZGN 937.3K
- AZTA 712.7K
- Earning Date
- ZGN 03-27-2025
- AZTA 05-07-2025
- Dividend Yield
- ZGN 1.96%
- AZTA N/A
- EPS Growth
- ZGN N/A
- AZTA N/A
- EPS
- ZGN 0.31
- AZTA N/A
- Revenue
- ZGN $2,015,371,157.00
- AZTA $662,108,000.00
- Revenue This Year
- ZGN $4.49
- AZTA N/A
- Revenue Next Year
- ZGN $5.90
- AZTA $5.44
- P/E Ratio
- ZGN $21.14
- AZTA N/A
- Revenue Growth
- ZGN 2.21
- AZTA 5.36
- 52 Week Low
- ZGN $6.39
- AZTA $31.09
- 52 Week High
- ZGN $14.17
- AZTA $63.58
- Technical
- Relative Strength Index (RSI)
- ZGN 26.65
- AZTA 22.62
- Support Level
- ZGN $7.07
- AZTA $33.33
- Resistance Level
- ZGN $8.10
- AZTA $35.80
- Average True Range (ATR)
- ZGN 0.32
- AZTA 1.76
- MACD
- ZGN -0.05
- AZTA -0.33
- Stochastic Oscillator
- ZGN 6.44
- AZTA 1.74
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.